Results for "Hyperbaric Oxygen Therapy" in Cancer

20 articles

Beta-Hydroxybutyrate Boosts CAR T Cell Cancer Fighting Power
Cancer Research

Beta-Hydroxybutyrate Boosts CAR T Cell Cancer Fighting Power

Ketogenic diet metabolite enhances CAR T cell metabolism and tumor control in multiple cancer models

Research Paper
Apr 5, 2026 0
Blocking Haem Signaling Revives Exhausted Cancer-Fighting T Cells
Cancer Research

Blocking Haem Signaling Revives Exhausted Cancer-Fighting T Cells

Scientists identify a mitochondria-proteasome-haem pathway that silences immune cells โ€” and show bortezomib can fix it in CAR-T therapy.

Research Paper
Jun 22, 2026 0
HBO1 Protein Drives Cancer Spread and Immunotherapy Resistance in Ovarian Cancer
Cancer Research

HBO1 Protein Drives Cancer Spread and Immunotherapy Resistance in Ovarian Cancer

New research identifies HBO1 as a key driver of cancer cell transformation and resistance to CAR-T cell therapy in ovarian cancer.

Research Paper
Apr 9, 2026 0
Blood-Brain Barrier Breakthrough Could Transform Brain Cancer Immunotherapy Delivery
Cancer Research

Blood-Brain Barrier Breakthrough Could Transform Brain Cancer Immunotherapy Delivery

New research reveals how brain barrier variations affect cancer treatment delivery, potentially improving outcomes.

Research Paper
Mar 29, 2026 0
Blood-Brain Barrier Variations Could Transform Brain Cancer Immunotherapy Delivery
Cancer Research

Blood-Brain Barrier Variations Could Transform Brain Cancer Immunotherapy Delivery

New research reveals how blood-brain barrier differences affect immunotherapy access, potentially improving brain cancer treatment.

Research Paper
Mar 29, 2026 0
BCG Bladder Cancer Treatment Reprograms Bone Marrow to Boost Tumor Immunity
Cancer Research

BCG Bladder Cancer Treatment Reprograms Bone Marrow to Boost Tumor Immunity

BCG therapy for bladder cancer travels to bone marrow, reprogramming stem cells to produce enhanced immune cells that fight tumors throughout the body.

Research Paper
Apr 2, 2026 0
Lipid Molecule 12-HETE Found to Cripple Immune Cells in Liver Cancer
Cancer Research

Lipid Molecule 12-HETE Found to Cripple Immune Cells in Liver Cancer

A newly identified lipid mediator may explain why immune cells fail to fight MASH-driven liver cancer, opening therapeutic targets.

Research Paper
May 21, 2026 0
New Triple Drug Combo Doubles Survival for Brain Metastases in HER2+ Breast Cancer
Cancer Research

New Triple Drug Combo Doubles Survival for Brain Metastases in HER2+ Breast Cancer

Tucatinib-based treatment extends survival from 4.4 to 10 months for women with breast cancer that spread to brain lining.

Research Paper
Mar 28, 2026 0
AI Model Predicts Liver Cancer Outcomes Using Oxygen and Immune Markers
Cancer Research

AI Model Predicts Liver Cancer Outcomes Using Oxygen and Immune Markers

New fusion model combines hypoxia and immune markers to predict hepatocellular carcinoma treatment success non-invasively.

Research Paper
Apr 4, 2026 0
Radiation Therapy Rivals Surgery for Early-Stage Liver Cancer in Largest Study Yet
Cancer Research

Radiation Therapy Rivals Surgery for Early-Stage Liver Cancer in Largest Study Yet

A multinational study of 4,913 patients finds EBRT delivers survival outcomes comparable to surgery and ablation for early hepatocellular carcinoma.

Research Paper
May 19, 2026 0
Chemotherapy Plus Hormones vs Hormones Alone for Older Women with High-Risk Breast Cancer
Cancer Research

Chemotherapy Plus Hormones vs Hormones Alone for Older Women with High-Risk Breast Cancer

ASTER 70s trial compares treatment intensities for women 70+ with genomically high-risk breast cancer to optimize outcomes while minimizing toxicity.

Research Paper
Apr 4, 2026 0
PARP Inhibitor Rechallenge Shows Promise for Recurrent Ovarian Cancer Treatment
Cancer Research

PARP Inhibitor Rechallenge Shows Promise for Recurrent Ovarian Cancer Treatment

New study reveals combining PARP inhibitors with bevacizumab extends progression-free survival in previously treated ovarian cancer patients.

Research Paper
Mar 29, 2026 0
Immunotherapy Plus T-DXd Shows Strong Results in HER2-Low Breast Cancer
Cancer Research

Immunotherapy Plus T-DXd Shows Strong Results in HER2-Low Breast Cancer

The BEGONIA trial finds durvalumab combined with trastuzumab deruxtecan achieves 62% response rate in hard-to-treat metastatic breast cancer.

Research Paper
Jun 9, 2026 0
Chemo-Free HER2+ Breast Cancer Treatment Achieves Excellent 5-Year Survival
Cancer Research

Chemo-Free HER2+ Breast Cancer Treatment Achieves Excellent 5-Year Survival

A randomized trial shows hormone receptor-positive/HER2+ early breast cancer patients had 100% 5-year overall survival with endocrine therapy plus dual HER2 blockade.

Research Paper
May 19, 2026 0
Pertuzumab Retreatment Extends Survival in HER2-Positive Breast Cancer by 10 Months
Cancer Research

Pertuzumab Retreatment Extends Survival in HER2-Positive Breast Cancer by 10 Months

Japanese trial shows dual HER2 blockade with pertuzumab plus trastuzumab improves overall survival even after prior pertuzumab treatment.

Research Paper
Apr 2, 2026 0
New Antibody Drug Shows Promise Against Advanced Lung Cancer in Clinical Trial
Cancer Research

New Antibody Drug Shows Promise Against Advanced Lung Cancer in Clinical Trial

B7-H3-targeted therapy HS-20093 achieved 52% response rate in small cell lung cancer and 22% in non-small cell lung cancer patients.

Research Paper
Mar 28, 2026 0
DCA Metabolic Conditioning Creates Superior Cancer-Fighting T Cells
Cancer Research

DCA Metabolic Conditioning Creates Superior Cancer-Fighting T Cells

Redirecting glucose metabolism during T cell expansion dramatically improves cancer immunotherapy effectiveness.

Research Paper
Mar 29, 2026 0
Mitochondria-Targeted Cancer Therapy Shows Promise for Boosting Tumor Immunity
Cancer Research

Mitochondria-Targeted Cancer Therapy Shows Promise for Boosting Tumor Immunity

New review reveals how targeting mitochondria in cancer cells could overcome immunotherapy resistance and enhance anti-tumor responses.

Research Paper
Apr 8, 2026 0
Local Therapy Shows Promise for Metastatic Lung Cancer Treatment
Cancer Research

Local Therapy Shows Promise for Metastatic Lung Cancer Treatment

New approach targets specific cancer sites in advanced lung cancer patients, potentially improving outcomes.

Research Paper
Mar 28, 2026 1
P53 Protein Controls Tumor Growth Through Oxygen-Sensing Mechanism
Cancer Research

P53 Protein Controls Tumor Growth Through Oxygen-Sensing Mechanism

New research reveals how the p53 tumor suppressor protein fights cancer by activating cell death pathways when oxygen levels drop.

Research Paper
Mar 29, 2026 1
Page 1 of 2Next